Morepen Laboratories Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 388.33 | 388.72 | 396.59 |
| Operating Expense | 340.64 | 337.03 | 336.46 |
| Net Profit | 31.93 | 35.05 | 39.96 |
| Net Profit Margin | 8.22 | 9.02 | 10.08 |
| Earning Per Share | 0.60 | 0.69 | 0.78 |
| EBIDTA | 47.70 | 51.68 | 60.56 |
| Effective Tax Rate | 22.91 | 23.22 | 21.92 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 388.33 |
| Operating Expense | 340.64 |
| Net Profit | 31.93 |
| Net Profit Margin | 8.22 |
| Earning Per Share | 0.60 |
| EBIDTA | 47.70 |
| Effective Tax Rate | 22.91 |
Invest in Morepen Laboratories Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 1,537.59 | 1,338.88 | 1,449.27 |
| Operating Expenses Annual | 1,375.77 | 1,261.61 | 1,320.13 |
| Operating Profit Annual | 174.38 | 83.03 | 139.37 |
| Interest Annual | 3.51 | 1.98 | -7.37 |
| Depreciation | 17.42 | 12.03 | 15.30 |
| Net Profit Annual | 110.94 | 46.24 | 101.06 |
| Tax Annual | 38.04 | 16.80 | 24.48 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 1,537.59 |
| Operating Expenses Annual | 1,375.77 |
| Operating Profit Annual | 174.38 |
| Interest Annual | 3.51 |
| Depreciation | 17.42 |
| Net Profit Annual | 110.94 |
| Tax Annual | 38.04 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 21.26 | 15.38 | 40.47 |
| Cash Flow from Operations | 77.36 | -102.12 | -68.87 |
| Cash Flow from Investing | -83.60 | -36.20 | -22.64 |
| Cash Flow from Financing | 0.28 | 144.20 | 66.41 |
| Cash Flow at the End | 15.30 | 21.26 | 15.38 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 21.26 |
| Cash Flow from Operations | 77.36 |
| Cash Flow from Investing | -83.60 |
| Cash Flow from Financing | 0.28 |
| Cash Flow at the End | 15.30 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 11.34 | 6.20 | 9.62 |
| PBIT Margin (%) | 9.92 | 4.86 | 8.15 |
| PBT Margin (%) | 7.09 | 2.41 | 9.26 |
| Net PROFIT Margin (%) | 7.22 | 3.45 | 6.97 |
| Return On Networth / Equity (%) | 13.29 | 6.71 | 19.38 |
| Return On Networth /Employed (%) | 17.08 | 8.78 | 20.85 |
| Return On Assets (%) | 12.41 | 6.25 | 17.85 |
| Total Debt / Equity (X) | 0.03 | 0.03 | 0.03 |
| Asset Turnover Ratio (%) | 1.72 | 1.81 | 2.56 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 11.34 |
| PBIT Margin (%) | 9.92 |
| PBT Margin (%) | 7.09 |
| Net PROFIT Margin (%) | 7.22 |
| Return On Networth / Equity (%) | 13.29 |
| Return On Networth /Employed (%) | 17.08 |
| Return On Assets (%) | 12.41 |
| Total Debt / Equity (X) | 0.03 |
| Asset Turnover Ratio (%) | 1.72 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 216.54 | 170.82 | 156.11 |
| Total Current Assets Annual | 842.91 | 730.85 | 676.76 |
| Non Current Assets Annual | 436.40 | 374.69 | 356.50 |
| Total Shareholders Funds Annual | 889.02 | 780.11 | 598.17 |
| Total Assets Annual | 1,279.31 | 1,105.54 | 1,033.26 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 216.54 |
| Total Current Assets Annual | 842.91 |
| Non Current Assets Annual | 436.40 |
| Total Shareholders Funds Annual | 889.02 |
| Total Assets Annual | 1,279.31 |
EPS (INR)
Expected
0.64
Reported
0.65
Surprise
1.56%
Jun 2024
EPS beaten by 1.56%
Mar 2024
EPS beaten by 0.00%
Dec 2023
EPS beaten by -1.82%
